Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00128375 · ClinicalTrials.gov registry record · NA

Financial Incentives for Smoking Cessation

A NA study of Tobacco Use Disorder, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
878
Enrollment target
1
Study location

NCT00128375: Completed NA study of Tobacco Use Disorder, sponsored by University of Pennsylvania.

NCT00128375 is a NA study of Tobacco Use Disorder that has completed, run by University of Pennsylvania. The registered enrollment target is 878 participants, above the 227-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (287% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00128375, a NA study of Tobacco Use Disorder, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
878 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test the effectiveness of financial incentives for increasing long-term smoking cessation rates among employees at General Electric worksites throughout the United States.

Conditions Studied

Interventions

  • BEHAVIORAL Financial incentives

Study Locations (1)

Pennsylvania

  • University of Pennsylvania School of Medicine - Philadelphia

Trial Details

FieldValue
Enrollment Target 878 participants
Start Date 2005-03
Est. Completion 2008-04
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT00128375

The ClinicalTrials.gov registry entry for NCT00128375 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 878 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 227-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (287% higher). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tobacco Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Financial incentives is the first listed.

NCT00128375 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00128375 about?

NCT00128375 is a clinical study titled "Financial Incentives for Smoking Cessation". The purpose of this study is to test the effectiveness of financial incentives for increasing long-term smoking cessation rates among employees at General Electric worksites throughout the United States.

What is the current status of trial NCT00128375?

This trial is currently completed. It is a NA study. The enrollment target is 878 participants. The study started on 2005-03. Estimated completion is 2008-04.

What conditions does trial NCT00128375 study?

This clinical trial studies the following conditions: Tobacco Use Disorder.

What interventions are being tested in trial NCT00128375?

The interventions under investigation include: Financial incentives (BEHAVIORAL).

Who is sponsoring clinical trial NCT00128375?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00128375 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.